F S&P 500
5,243.25 +4.25 (+0.08%) F Dow Jones
39,578.00 +42.00 (+0.11%) F Nasdaq
18,224.00 +9.50 (+0.05%) E-mini Russell 2000 Index Futur
2,086.00 +1.90 (+0.09%) Petróleo
79.79 +0.53 (+0.67%) Oro
2,359.60 +19.30 (+0.82%)
BlackRock Health Sciences Trust (BME)
BlackRock Health Sciences Trust
50 Hudson Yards
New York, NY 10001
United States
212 810 5300
https://www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund
Sector(es): Financial Services
Industria: Asset Management
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Charles Choon Sik Park | Chief Compliance Officer and Anti-Money Laundering Officer | N/D | N/D | 1967 |
| Mr. Thomas P. Callan C.F.A. | Portfolio Manager | N/D | N/D | N/D |
| Mr. Kyle G. McClements C.F.A. | Portfolio Manager | N/D | N/D | N/D |
| Dr. Erin Xie Ph.D. | Portfolio Manager | N/D | N/D | 1968 |
| Mr. Christopher M. Accettella | Portfolio Manager | N/D | N/D | N/D |
| Mr. Jeffrey Gene Lee | Portfolio Manager | N/D | N/D | N/D |
| Dr. Xiang Liu Ph.D. | Portfolio Manager | N/D | N/D | N/D |
Descripción
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Gestión corporativa
La calificación ISS Governance QuickScore de BlackRock Health Sciences Trust a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
